NewsSource: EClinCloud

Invitation | Meet EClinCloud at ChinaTrials Shanghai

3 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: eClinCloud.


Click the blue text above to follow us

Article image


Article image



The 13th ChinaTrials Clinical Development Leaders Summit will be held in Shanghai from November 10 to 12, 2021. The summit brings together key opinion leaders from drug development strategy, regulatory affairs, clinical operations, clinical statistics, and many other fields to discuss and advance the development of clinical research in China.


Event Information


Dates: November 10–12, 2021

Location: 399 West Nanjing Road, Huangpu District, Shanghai

          JW Marriott Hotel Shanghai at Tomorrow Square, 5th Floor


Article image

EClinCloud Booth: Booth 6 (indicated by the arrow in the figure)


Generous gifts will also be available at the EClinCloud booth. We look forward to your participation!

Article image



Conference Agenda



Thursday, November 11

07:30 - 08:15 

Registration and Check-in

08:15 - 08:30 

Opening Remarks

08:30 - 09:00 

Chinese Biotech Innovation Steps onto the Global Stage

09:00 - 10:00 

Inflection Point in China's Biopharma Innovation: Considerations on Risks and the Path Forward

10:00 - 10:20 

Tea Break

10:20 - 11:10 

Multinational Pharma Perspective: China's New Role in Global Drug Development

11:10 - 12:00 

On the Road to Combating Viruses

12:00 - 12:40 

Global Drug Development 2.0: Pharmaceutical Innovation Without Borders

12:40 - 13:40 

Lunch

13:40 - 14:00 

Optimal Strategies for Rapid Transition from Phase I to Phase II Clinical Trials

14:00 - 15:00 

China Medical Officer Roundtable: What Are Top Chief Medical Officers in China Thinking About?

15:00 - 15:55 

Decentralized Clinical Trials: How COVID Is Changing Clinical Development & Case Sharing

15:55 - 16:20 

Tea Break

16:20 - 17:20 

Investigator, Site, and Sponsor Perspectives: Digital Technologies Supporting Remote Monitoring to Accelerate Clinical Research


Friday, November 12

08:25 - 08:30 

Opening Remarks

08:30 - 09:30 

Selecting the Right Clinical Development Strategy to Optimize Regulatory Approval Pathways

09:30 - 10:30 

Co-Development of Drugs Between Chinese Biotech Companies and Multinational Pharma

10:30 - 11:00 

Tea Break

11:00 - 12:00 

Clinical Development of Cell Therapies: After the First Approval in China, What Can We Expect Next?

12:00 - 13:00 

The Future of Alzheimer's Disease Drug Development in China

13:00 - 13:50 

Lunch

13:50 - 14:40 

Clinical Trial Patient Recruitment Amid China's Innovative Drug Boom

14:40 - 15:30 

Real-World Data: A Faster Path to Delivering Innovative Therapies to Patients?

15:30 - 16:30 

Making Full Use of Expedited Drug Registration and Review Pathways

16:30 

Conference Closing



EClinCloud looks forward to seeing you at ChinaTrials!


Article image


EClinCloud

EClinCloud delivers effective treatments to patients through innovative, patient-centric decentralized intelligent solutions. We provide an integrated all-in-one cloud platform (including solutions such as CTMS, EDC, eTMF, eCOA, eConsent, and RTSM, as well as consulting services including scale management, linguistic validation, and study design) and clinical trial endpoint assessment technologies across therapeutic areas (oncology, neurology, cardiology, pulmonology, dermatology, etc.). Combining cutting-edge technology with life data, we build a world-leading, patient-centric clinical evidence support SaaS cloud platform to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.
Article image


Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.